The absolute adult and fetal hemoglobin (HbF) contents of the erythroid cells derived from the differentiation of normal human and simian erythroid progenitors and of the peripheral blood erythroid burst-forming units (BFU-E) of patients with nondeletion hemoglobinopathies have been measured with a sensitive radioligand immunoassay. The HbF content varied between 0.13 and 2.96 pg/cell, representing between 0.7% and 19
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L. Abbreviations used in this paper: BFU-E, erythroid burst-forming unit(s); BPA, burst-promoting activity; CFU-E, erythroid colony-forming unit(s); CFU-GEMM, granulocyte, erythroid, monocyte, macrophage CFU(s); HbA, adult hemoglobin; HbF, fetal hemoglobin; IMDM, Iscove's modified Dulbecco's medium. to estimate the HbF program within individuals and families. Estimation of this program by means of analysis of the HbF content of marrow precursors or circulating cells may be misleading. Nearly all of the HbF in the circulation is packaged in a subset of F erythrocytes or F reticulocytes that contain from 10 to 30% HbF (1, 2) . The number of F cells and their HbF contents may not reflect the actual capacity of the individual to produce HbF in erythroid cells because the life span of F cells or F reticulocytes in such hemolytic anemias may radically differ from that of non-F cells (3) . Indeed, in some cases of (3-thalassemia, F erythroblasts are apt to be relatively spared the consequences of ineffective erythropoiesis (4) . In 1968, Hall and Motulsky (5) demonstrated that marrow cultured in vitro synthesizes more HbF than is produced in vivo. Later Papayannopoulou and co-workers (6) showed that the progeny of committed adult erythroid progenitors synthesize considerable quantities of HbF. The capacity to measure HbF in colonies derived in vitro from erythroid progenitors would obviate the problems of selection that confound studies of erythrocytes, reticulocytes, and erythroid precursors in vivo. However, this type of measurement is rendered complex by conflicting observations concerning the influence of progenitor maturity on the amount of HbF produced in the colonies derived from them. For example, Papayannopoulou and her co-workers (6) concluded that more primitive erythroid progenitors give rise to colonies that contain more HbF and that the potential to express HbF is progressively lost during normal erythroid progenitor maturation. It was thus proposed that F cells are the result of premature commitment to terminal differentiation by progenitors that still have considerable HbF potential.
That erythroid colonies derived from progenitors synthesize considerable quantities of HbF has been confirmed in many laboratories, but there have been major discrepancies in the reports of the amount of hemoglobin synthesized and disagreement about the progenitor level at which the ability to synthesize HbF is lost (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . There have also been conflicting reports, using immunofluorescence or hemoglobin synthesis studies, that high concentrations of crude erythropoietin (11, 16, 19) or supernatants that contain burst-promoting activity (BPA) (8, 15) can enhance HbF synthesis in progenitor-derived colonies.
Just as cell selection confounds assessment of the HbF program by measurement of HbF in erythroblasts and circulating cells, studies of HbF in erythroid colonies may also suffer from technical limitations that lead to the conflicting reports cited above. Immunofluorescent techniques to detect HbF are essentially qualitative and provide little information about fractional HbF content. Measurement of hemoglobin synthesis in progenitor-derived colonies over a 24-h period has also been severely criticized because of the potential for asynchrony of hemoglobin production during colony devel-opment (14, (20) (21) (22) BFU-E were all induced to form colonies in the continuous presence of 2.0 U of erythropoietin per/ml, erythroid colony-forming units (CFU-E) in 0.5 and 2.0 U, and granulocyte, erythroid, monocyte, macrophage CFU(s) (CFU-GEMM) in the presence of 1.0 U of erythropoietin per/ml. The plates were incubated in humidified 4% CO2 at 370C. Marrow CFU-E-derived colonies were cultured for 7-8 d whereas peripheral blood and marrow BFU-E-derived colonies were cultured for 14 d. For growth of CFU-GEMM colonies, 5% (vol/vol) giant cell tumor-conditioned medium (Gibco Laboratories) as a source of colony-stimulating activity and 5% Mo cell line-conditioned medium as a source of BPA were included in the culture mixture from its inception, but the addition of erythropoietin was delayed until days 3-5 when 1 U/ml was added. The culture was then continued for a total of 14 d.
Sample preparation for hemoglobin assay. Erythroid colonies (-20 BFU-E-or CFU-GEMM-derived and 100-200 CFU-E-derived) were plucked with a drawn out pasteur pipette, pooled in 0.3-0.5 ml of IMDM, 4VC, and resuspended. 20 ,g of this was taken for cell counting in a hemocytometer. A precisely measured volume was then transferred to a second tube and pelleted. The supernatant was carefully aspirated with a drawn out pipette and the pellet was resuspended in a precisely measured volume of 0.5 mg/ml carrier sheep hemoglobin (300-400 Ml) containing 0.02% Na-azide. This suspension was sonicated in an Eppendorf tube, microcentrifuged to remove cell debris, and stored at 4VC. Samples were routinely assayed within 10 d of preparation. In some experiments, intermediate and well-hemoglobinized BFU-E-derived colonies were removed separately and pooled.
Hemoglobin preparation, assay, and HbF determination. Hemoglobin from adult blood, cord blood, or sheep blood samples were obtained by CC14 lysis of washed cells, the stroma being removed by centrifugation. Fresh samples were prepared every 3 wk. The hemoglobin concentration was measured spectrophotometrically as cyanmethemoglobin and the percentage of HbF was determined by alkali denaturation. The adult and cord blood samples were used to construct standard curves.
Radioligand immune assay for HbA and HbF. HbA and HbF standards were prepared as above and diluted with 0.5 mg/ml sheep hemoglobin. Sonicated cell extracts derived from erythroid colonies were also diluted with 0.5 mg/ml sheep hemoglobin. 2-3 dilutions were routinely assayed as previously described (23) .
Linear standard curves were consistently obtained, and the hemoglobin in 3,000-10,000 cells was routinely assayed. Dilutions of a given sample or the same sample assayed on separate days yielded results within 10% of the mean. Though the majority of samples analyzed represent colonies pooled from duplicate or triplicate plates, when individual plates were examined the variability of percentage of HbF between plates was <10% of the mean value.
A further error was induced by estimation of the total hemoglobin or HbF per cell in these erythroid colonies. The reliability of this determination was based upon the accuracy of enumeration of erythroid cells in the hemocytometer. The variability of this procedure was found to be -5-l10o, but was no less than 10% with respect to CFU-GEMM colonies in that this required an additional assessment of the percentage of erythroid cells within the pooled colonies. It must be emphasized that the expression picograms of total hemoglobin or HbF per cell utilized in this report represents a mean value and not the actual concentration in each cell. Some samples of our pooled colonies were kindly examined by Dr. George Dover, Johns Hopkins University School of Medicine, Baltimore, MD, who found that -50% of the cells in either CFU-E or BFU-E derived colonies had undetectable levels of hemoglobin F (<3 pg/cell). This 50% detectable F cell frequency is a value similar to that which Dover et 
Results
Culture characteristics. Under the culture conditions used in this study, human CFU-E-derived colonies become well hemo- 18.5±2.4
The data represent the means and standard deviations of erythroid progenitor-derived colony frequencies and sizes (as estimated from the number of erythroid cells per colony) and the total hemoglobin content per cell within each class of colony. The data presented in Fig. 3 Table I , the mean CFU-E-derived colony size reported is higher than expected. In more recent experiments such as those described in Fig. 3 and its legend, CFU-E-derived colony size was considerably lower, though the hemoglobin contents remain the same. As will be seen below, the hemoglobin content of a mixed population of marrow erythroblasts is 18 pg/cell, and this is the value often observed by us in the erythroid cells derived from immature progenitors. This was also the amount observed by Javid and Pettis (27) , but is considerably higher than the hemoglobin contents estimated by Dean and coworkers (28), who also utilized a radioimmunoassay to measure total hemoglobin and HbF in immature progenitor-derived colonies. HbF and HbA content oferythroid colonies grown in vitro. and 2 was that some CFU-E-derived colonies could survive until 14 d and obscure any difference in the hemoglobin content of the BFU-E. In three experiments therefore, all wellhemoglobinized colonies were sterilely removed from the culture plates before day 12 and the plates were then incubated for several more days. A cohort of new well-hemoglobinized BFU-E colonies could then be obtained wihout any risk of CFU-E colony contamination. When these colonies were analyzed there was again no significant difference between the CFU-E-and BFU-E-derived colony HbF contents (Table II) . Another possible source of confusion might have arisen as a result of contamination of well-hemoglobinized CFU-E colonies at day 7 by the immature products of BFU-E colony formation undergoing asynchronous hemoglobin synthesis or by the fact that some of the larger 7-d colonies inherently represent the BFU-E-derived colonies. Such BFU-E-derived colonies might have contributed HbF but not HbA to the CFU-E-derived colony hemoglobin. But studies of peripheral blood BFU-Ederived colonies from day 7 through day 14, uncontaminated by CFU-E-derived colonies because CFU-E are not present in blood, demonstrate that HbF is barely detectable in them at day 7 (data not shown). Therefore, we conclude that values displayed in Figs. 1 and 2 fairly represent the actual hemoglobins that accumulated in the indicated colonies. It has been suggested that the BFU-E circulating in the peripheral blood are more primitive than most marrow BFU-E (29) , and a previous study in our laboratory in which we measured fractional HbF synthesis suggested that it was considerably higher in blood-derived BFU-E colonies than in marrow BFU-E colonies (11) . The HbF and HbA content of paired samples of well-hemoglobinized blood and marrow BFU-E colonies were therefore determined for four individuals, and the results are given in Table III . As predicted from the data in Fig. 1 no significant difference was seen.
In a further series of experiments the blood or marrow CFU-GEMM colonies of six individuals were isolated and the hemoglobin content in the cells of pooled colonies compared with that found in paired cultures of blood or marrow BFU-E. A cytocentrifugate was also made of the pooled mixed colonies to determine their percentages of erythroid cells. The average HbA and HbF content per erythroid cell is shown in Table IV where it is apparent that the percentage of HbF content of CFU-GEMM-derived colonies is similar to the corresponding BFU-E-derived colonies. CFU-GEMM may be induced to form colonies after delayed erythropoietin addition. Therefore, in three experiments BFU-E-derived colonies were also plucked from these plates. The hemoglobin content of these BFU-E-derived colonies did not differ significantly from 5 and 8, respectively, and of four human marrows on days 7 and 14, respectively. The human marrows were in addition to those included in Table I and described above. The results shown in Fig. 3 clearly demonstrate a major difference between simian and human progenitors with respect to the HbF program. Simian BFU-E-derived colonies have much higher HbF contents than do those of humans. The difference remains but is less dramatic at the level of CFU-E because the HbF program expressed in simian CFU-E-derived colonies is much lower than in BFU-E. In contrast, the HbF program expressed in the four different samples of human erythroid progenitor-derived colonies is relatively constant whether the colonies arise from BFU-E or CFU-E. In this study, CFU-E-derived colonies were considerably smaller than those described above.
In these studies of simian marrow, adherent cells were removed from an aliquot of the low-density cell fractions before their culture. No influence of this maneuver on the HbF accumulation could be detected (data not shown).
Hemoglobin content ofmarrow erythroblasts. The peripheral blood of marrow 7 in Fig. 1 cells. However, Fig. 4 A demonstrates that this 20-fold increase in erythropoietin concentration and fourfold increase in total erythroid cell production has no effect on the HbF and HbA accumulation in the marrow BFU-E-derived colonies. It should be emphasized that this experiment indirectly suggests that exogenous BPA also has no effect on the expression of HbF in human marrow BFU-E-derived colonies because the eryth- The lack of influence of erythropoietin on HbF accumulation in CFU-E-derived colonies is shown in Fig. 4 B. Here the progenitors were cultured only at 0.5 and 2 U of erythropoietin, because at lower concentrations, the colonies were too small to be plucked effectively. No After having established conditions in which the capacity to express HbF in the erythroblasts proximally derived from erythroid progenitors is not detectably influenced by progenitor maturity, we next set out to estimate the HbF program as it is expressed in the erythroblasts derived from the peripheral blood BFU-E of several individuals with different 13-chain In contrast, a patient with sickle cell anemia and a nondeletion form of hereditary persistence of HbF, whose total circulating HbF was >30%, had an extraordinarily high HbF program expressed in peripheral blood BFU-E, as did her mother, a patient with hemoglobin S trait who, in fact, had 4% HbF present in her circulating blood. It is likely that this patient with SS disease inherited a form of hereditary persistence of HbF as well as a (3-S gene from her mother.
None of the above results could be explained by alterations in colony growth. The erythroid cells per colony in the cultures of the patients and family members ranged from 9.3 to 34.6 (XI03) and were very similar in each case to normal controls cultured simultaneously.
Discussion
This study confirms that the progeny of human erythroid progenitor cells grown in vitro contain more HbF than is found in marrow erythroblasts or peripheral erythrocytes. However, the average amount of HbF per cell grown in vitro is quite low. In our hands, it varies between 0.13 and 2.96 pg/ cell representing between 0.7 and 19.6% of total hemoglobin in well-hemoglobinized colonies derived from CFU-E, marrow BFU-E, blood BFU-E, and CFU-GEMM. The mean fractional HbF content of all well-hemoglobinized colonies in all experiments was 7.0±4.6% which is considerably less than that reported by many workers who measured hemoglobin synthesis over a single 24-h period in culture (7-1 1) and is in agreement with the values for the progeny of peripheral blood BFU-E determined by Javid et al. (27) using the same radioligand immunoassay and for those of marrow BFU-E determined by Dover et al. (26) using a quantitative immunoprecipitation technique. In the latter study, the HbF/F cell in marrow BFU-E colonies was found to be 6.2 pg but only 40% of the total cells were F cells as defined in that study.
Whereas in the rhesus monkey (24) and in M. fascicularis the erythroid cells derived from more immature progenitors contain more HbF (two-to fourfold difference from CFU-E to BFU-E), this is not the case in normal humans, there being no difference under the described experimental conditions 'between the HbF contents of the colonies derived from CFU-E, marrow BFU-E, blood BFU-E, and CFU-GEMM. Therefore, erythroid differentiation in humans does not appear to recapitulate ontogeny with respect to potential for HbF production. The studies of Dover et al. (26) have suggested that there is a little less HbF per F cell in CFU-E derived colonies compared with colonies derived from BFU-E, whereas we found no significant difference in the average HbF content per cell in these classes of colonies. This discrepancy may result from differences in culture conditions and indeed the CFU-E-derived colonies grown under our conditions are sometimes larger than those described by Dover et al. (26) . Furthermore, the average total hemoglobin content per cell for CFU-E in this study was 11.8±2.7 pg/cell compared with 16.0±6.2 pg/cell in the corresponding marrow BFU-E so that the cells in the CFU-E derived colonies cultured for only 7 d may have been a little less mature with consequent over estimation of their fractional if not their absolute HbF content. It should be noted however that no differences were detected in the morphology of the erythroid cell in CFU-E-and BFU-E-derived colonies. What is clear is that in normal humans, the potential for HbF production in erythroblasts immediately derived from the most primitive progenitors (CFU-GEMM) is very limited and remains constant throughout progenitor maturation. The major step down in -y-globin gene expression occurs after the CFU- (24) . We do not know the molecular basis of this step down, but have previously suggested that general understanding of the observation requires quantitative consideration of the numbers of the reticulocytes produced by erythroblasts proximately derived from progenitors (24) . Our calculations, based on previously published data persuade us that such reticulocytes represent only a small fraction of the daily reticulocyte production in normal individuals. They may be the precursors of the few F cells found in the normal circulation. In contrast, the majority of circulating erythrocytes, the non-F cells, are products of reticulocytes that were likely to have been derived from proerythroblasts that underwent one or more rounds of quantal division (30) before they completed the process of terminal differentiation. We believe that, as proerythroblasts undergo quantal division in vivo, they must lose their capacity to express the inherent H$F program present at the progenitor level. Hence, under normal conditions marrow erythroblasts contain far less HbF than do erythroblasts immediately derived from progenitors in vitro. Erythropoietic stress is accompanied by a vast increase in the fraction of proerythroblasts proximally derived from progenitors. Quantal division is bypassed in favor of immediate terminal differentiation. Therefore, the HbF program is retained in a much larger proportion of proerythroblasts and F reticulocytes and F cells increase pari passu.
In the primate studies reported by Macklis et al. (24) it was suggested that crude erythropoietin preparations and BPA may modify y-globin gene expression, and in previous studies of humani BFU-E it was shown that crude erythropoietin (contaminated with BPA) enhanced HbF synthesis whereas pure erythropoietin had no effect on HbF synthesis (8) . In the study reported here, 20-fold increments of erythropoietin known to be contaminated with BPA increased the incidence and size of progenitor-derived colonies but had no effect on the final HbF or HbA content per cell. Clarke and Housman similarly found no effect of crude erythropoietin on HbF synthesis (19) . We conclude that in normal humans, BPA (Fig. 5) . These experiments suggest that under optimal conditions asynchrony is present only in the very earliest stages of progenitor-derived colony growth and that marked asynchrony in the later stages of colony growth is a feature of suboptimal culture conditions. One of the benefits of the radioligand immunoassay used in this study is that the total hemoglobin content per cell can be determined, acting as a check on culture conditions and colony maturity. We would suggest that if the average blood BFU-E size is <5,000 cells or the Hb content per cell <10 pg/cell, then great caution should be used in interpreting fractional HbF contents. It is likely that suboptimal culture conditions or the harvesting of colonies prior to full hemoglobinization may have contributed to some of the higher values for relative HbF synthesis in vitro previously reported. Dean et al. (28) also measured Hb contents by a radioimmunoassay and found that day 15 bursts contained 25% HbF. However, the BFU-Ederived colonies analyzed in that study contained fewer cells than in the present study, and the mean corpuscular hemoglobin was <10 pg per cell.
Alteration of the HbF program has particular relevance to future treatment of patients with hemoglobinopathies, and the use of cytotoxic/cytostatic drugs to increase HbF production has aroused much interest (33, 34). Cell cycle specific cytotoxic agents would be expected to inhibit erythroblasts or highly erythropoietin responsive cells preferentially (35) , forcing the remaining less rapidly cycling progenitor cells to undergo premature terminal differentiation. This perturbation of the progenitor and precursor cell pools might in itself increase HbF production independent of any drug effect on globin gene function. But the studies reported here also suggest that such a drug effect would induce an increment of HbF production of only 0.13-2.96 pg/cell or 1-20% of the mean corpuscular hemoglobin in the erythrocytes of normal individuals.
The HbF program within the erythroid progenitcrs of patients with nondeletion B chain hemoglobinopathies might differ considerably from thai of normal Caucasian volunteers because there is considerable evidence that the B chain hemoglobinopathies arose in some cases on a chromosome background that differs with respect to the globin gene complex from that of most Caucasians without hemoglobinopathy (36) . Some of these gene complexes might induce much higher y-gene output in the erythroblasts that proximally arise as a result of the differentiation of progenitors. Indeed the variable fraction of F cells in patients with hemoglobinopathies (36, 37) may be in part related to such a mechanism.
Our preliminary evaluation of patients with various forms of nondeletion 13-thalassemia and sickle cell disease and a very small sample of heterozygotes amply confirms the heterogeneity of the HbF program in the peripheral blood BFU-E of such patients. Some of the patients and family members produced an amount of HbF in BFU-E-derived colonies that was within the normal range or only slightly higher. Others produced very large amounts of HbF. This evaluation of patients must be considerably expanded and careful family studies carried out to determine the patterns of inheritance of the HbF program (38) (39) (40) . Then an approach to the molecular basis of the differences in these programs can be instituted. It will be of particular interest to determine whether the HbF response to cytotoxic/cytostatic drug therapy in humans is in any way predicted by the intrinsic HbF program detected in progenitors.
